PRTA - Prothena Corporation plc

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-116,949
-116,949
66,975
-111,144
-77,677
Depreciation & amortisation
744
744
6,803
6,977
6,820
Deferred income taxes
-11,133
-11,133
4,573
-1,688
-1,248
Stock-based compensation
31,322
31,322
24,658
22,014
23,585
Change in working capital
-18,803
-18,803
-10,404
3,479
-4,449
Accounts receivable
-
-
15
53
-
Accounts payable
11,865
11,865
-492
7,728
-78
Other working capital
-109,285
-109,285
92,030
-80,558
-53,524
Other non-cash items
5,997
5,997
-
-
-
Net cash provided by operating activities
-108,821
-108,821
92,605
-80,362
-52,969
Cash flows from investing activities
Investments in property, plant and equipment
-464
-464
-575
-196
-555
Net cash used for investing activities
-464
-464
-575
-196
-547
Cash flows from financing activities
Debt repayment
-
-
-
0
-
Common stock issued
223,616
223,616
174,788
0
-
Net cash used provided by (used for) financing activities
241,457
241,457
190,332
215
228
Net change in cash
132,172
132,172
282,362
-80,343
-53,288
Cash at beginning of period
580,446
580,446
298,084
378,427
431,715
Cash at end of period
712,618
712,618
580,446
298,084
378,427
Free cash flow
Operating cash flow
-108,821
-108,821
92,605
-80,362
-52,969
Capital expenditure
-464
-464
-575
-196
-555
Free cash flow
-109,285
-109,285
92,030
-80,558
-53,524